ClinicalTrialsFinder

Diffuse Large B-cell Lymphoma Recurrent Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL

Diffuse Large B-cell Lymphoma RecurrentDiffuse Large B Cell Lymphoma Refractory
Tianjin Medical University Cancer Institute and Hospital22 enrolled1 locationNCT06570447